Diagnosis, investigation and treatment of delayed puberty in children

Paediatrics and Child Health

Volumn 17, Issue 9, 2007, Pages 349-355

  Mushtaq, T ^a   Wales, J K ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

delayed puberty; diagnosis; testosterone; treatment

Indexed keywords

AROMATASE; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FOLLITROPIN RECEPTOR; GONADORELIN DERIVATIVE; GROWTH HORMONE; LUTEINIZING HORMONE RECEPTOR; MEDROXYPROGESTERONE; OXANDROLONE; SEX HORMONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ANAMNESIS; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CLINICAL FEATURE; DELAYED PUBERTY; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; GENE MUTATION; GONADAL DYSGENESIS; HORMONAL THERAPY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; KARYOTYPE 47,XXX; KLINEFELTER SYNDROME; LOW DRUG DOSE; OVARY INSUFFICIENCY; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; TESTIS DISEASE; TURNER SYNDROME;

EID: 34548425231     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.06.005     Document Type: Article

References (23)

1. Argente J. Diagnosis of late puberty. Horm Res 51 suppl 3 (1999) 95-100
2. Frisch R.E. Fatness, menarche, and female fertility. Perspect Biol Med 28 (1985) 611-633
3. Theodoropoulou A., Markou K.B., Vagenakis G.A., et al. Delayed but normally progressed puberty is more pronounced in artistic compared with rhythmic elite gymnasts due to the intensity of training. J Clin Endocrinol Metab 90 (2005) 6022-6027
4. Staessen J.A., Nawrot T., Hond E.D., et al. Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet 357 (2001) 1660-1669
5. Kalantaridou S.N., and Chrousos G.P. Clinical review 148: monogenic disorders of puberty. J Clin Endocrinol Metab 87 (2002) 2481-2494
6. Strobel A., Issad T., Camoin L., et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18 (1998) 213-215
7. Stanhope R., Adams J., Jacobs H.S., et al. Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child 60 (1985) 116-119
8. Kubini K., Zachmann M., Albers N., et al. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 85 (2000) 134-138
9. Crowne E.C., Shalet S.M., Wallace W.H., et al. Final height in boys with untreated constitutional delay in growth and puberty. Arch Dis Child 65 (1990) 1109-1112
10. Cannavo S., Curto L., and Trimarchi F. Exercise-related female reproductive dysfunction. J Endocrinol Invest 24 (2001) 823-832
11. Brook C.G. Treatment of late puberty. Horm Res 51 suppl 3 (1999) 101-103
12. Wickramasuriya N., and Kirk J.M.W. Oestrogen replacement: micrograms or milligrams. Proc Br Soc Paediatr Endocrinol Diabetes P19 (2006) 42
13. Kiess W., Conway G., Ritzen M., et al. Induction of puberty in the hypogonadal girl-practices and attitudes of pediatric endocrinologists in Europe. Horm Res 57 (2002) 66-71
14. Johannsson G., Burman P., Wiren L., et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87 (2002) 2046-2052
15. Behre H.M., Oberpenning F., and Nieschlag E. Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation. In: Nieschlag E., and Behre H.M. (Eds). Testosterone action, deficiency, substitution (1990), Springer-Verlag, Berlin 115-135
16. Butler G.E., Sellar R.E., Walker R.F., et al. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth. J Clin Endocrinol Metab 75 (1992) 37-44
17. Tse W.Y., Buyukgebiz A., Hindmarsh P.C., et al. Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty. J Pediatr 117 (1990) 588-591
18. Stahnke N., Keller E., Landy H., and Serono Study Group. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab 15 (2002) 129-138
19. Vottero A., Pedori S., Verna M., et al. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone. J Clin Endocrinol Metab 91 (2006) 1284-1287
20. Mayo A., Macintyre H., Wallace A.M., et al. Transdermal testosterone application: pharmacokinetics and effects on pubertal status, short-term growth, and bone turnover. J Clin Endocrinol Metab 89 (2004) 681-687
21. Brachet C., Vermeulen J., and Heinrichs C. Children's virilization and the use of a testosterone gel by their fathers. Eur J Pediatr 164 (2005) 646-647
22. Hero M., Wickman S., and Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol 64 (2006) 510-513
23. Hero M., Ankarberg-Lindgren C., Taskinen M.R., et al. Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition. Eur J Endocrinol 155 (2006) 453-460